Latin America Molecular Point of Care Diagnostics Market 2019-2028

MARKET OUTLOOK

According to an analysis by the publisher, it is determined that the molecular point of care diagnostics market in Latin America will progress with a CAGR of 14.09% in the forthcoming period 2019-2028.
Brazil, Mexico and the Rest of Latin America together form the molecular point of care diagnostics market in Latin America.

The molecular point of care diagnostics market in Latin America is still in its nascent phase, as compared to the rapid developments in other parts of the world. Many Latin American countries, like Brazil, Argentina, and Mexico, are rigorously trying to promote the adoption of precision medicine solutions, including molecular point of care diagnostics. The adoption of precision medicine is experiencing a sudden growth owing to the rising standard of care, with advanced technologies entering the market.

However, currently, the Latin American countries are lagging than the developing parts of other regions, particularly in the adoption of point of care diagnostics. Although the escalating adoption of precision medicine in the US has directly impacted Mexico, there is still a long way of development left to ensure the potential growth of molecular point of care diagnostics within all countries in the region.

Besides, the differing regulatory processes between different countries for targeted therapies & molecular diagnostics market are acting as hurdles for pharmaceuticals and diagnostic companies to deploy new technologies across Latin America. But, the government is initiating favorable programs in order to create awareness about molecular diagnostics among regional vendors. This is likely to ensure the escalation in point of care technology adoption in Latin America.

COMPETITIVE OUTLOOK

Some of the major players in the molecular point of care diagnostics market are Biocartis, QuantuMDx Group Ltd, Danaher, Abbott, Biomerieux SA, Qiagen and F Hoffmann-La Roche Ltd.

1. Latin America Molecular Point of Care Diagnostics Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Increased Geriatric Population Requires More Diagnostic Services
2.2.2. Opportunities from Emerging Countries for the Market
2.2.3. Hybridization of Available Technologies is a Promising Trend
2.3. Porter's Five Force Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute
2.3.3. Bargaining Power of Suppliers
2.3.4. Bargaining Power of Buyers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Market Drivers
2.6.1. Demand for Diagnosing Presence of Sars Cov-2
2.6.2. Increasing Demand for Non-Invasive Diagnosis
2.6.3. Rise in the Number of Diseases
2.7. Market Restraints
2.7.1. High Capital Requirement
2.8. Market Opportunities
2.8.1. Spending on Research & Development
2.8.2. Innovations in the Market
2.9. Market Challenges
2.9.1. Lack of High Complexity Testing Centers

3. Latin America Molecular Point of Care Diagnostics Market Outlook – by Product

3.1. Assays
3.2. Instruments
3.3. Software

4. Latin America Molecular Point of Care Diagnostics Market Outlook - by Application

4.1. Infectious Disease
4.1.1. Respiratory
4.1.2. Hospital-Acquired Infections
4.1.3. Sexually-Transmited Infections
4.1.4. Gastrointestinal Infections
4.2. Oncology
4.3. Prenatal
4.4. Others

5. Latin America Molecular Point of Care Diagnostics Market Outlook - by Technology

5.1. Polymerase Chain Reaction
5.1.1. Real-Time Pcr (Q-Pcr)
5.1.2. Digital Pcr (D-Pcr)
5.2. Isothermal Nucleic Acid Amplification Technology
5.3. Other

6. Latin America Molecular Point of Care Diagnostics Market Outlook - by End-User

6.1. Hospital
6.2. Clinics
6.3. Diagnostic Centers
6.4. Others

7. Latin America Molecular Point of Care Diagnostics Market – Regional Outlook

7.1. Brazil
7.2. Mexico
7.3. Rest of Latin America

8. Competitive Landscape

8.1. ABBott
8.2. Abacus Diagnostica
8.3. Biomerieux Sa
8.4. Biocartis
8.5. Danaher
8.6. Diasorin Spa
8.7. Bio-Rad Laboratories Inc
8.8. F Hoffmann-La Roche Ltd
8.9. Luminex Corporation
8.10. Hologic Inc
8.11. Mesa Biotech
8.12. Spartan Biosciences Inc
8.13. Quantumdx Group Ltd
8.14. Quidel Corporation
8.15. Qiagen

9. Methodology & Scope

9.1. Research Scope
9.2. Sources of Data
9.3. Research Methodology

List of Tables

Table 1: Latin America Molecular Point of Care Diagnostics Market, by Country, 2019-2028 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Latin America Molecular Point of Care Diagnostics Market, by Product, 2019-2028 (In $ Million)
Table 5: Latin America Molecular Point of Care Diagnostics Market, by Application, 2019-2028 (In $ Million)
Table 6: Latin America Molecular Point of Care Diagnostics Market, by Infectious Disease, 2019-2028 (In $ Million)
Table 7: Latin America Molecular Point of Care Diagnostics Market, by Technology, 2019-2028 (In $ Million)
Table 8: Latin America Molecular Point of Care Diagnostics Market, by Polymerase Chain Reaction, 2019-2028 (In $ Million)
Table 9: Latin America Molecular Point of Care Diagnostics Market, by End-User, 2019-2028 (In $ Million)
Table 10: Latin America Molecular Point of Care Diagnostics Market, by Country, 2019-2028 (In $ Million)

List of Figures

Figure 1: Porter's Five Force Analysis
Figure 2: Cost Comparison Between Laboratory, Immunoassay and Molecular Poc Diagnostic Tests
Figure 3: Latin America Molecular Point of Care Diagnostics Market, by Assays, 2019-2028 (In $ Million)
Figure 4: Latin America Molecular Point of Care Diagnostics Market, by Instruments, 2019-2028 (In $ Million)
Figure 5: Latin America Molecular Point of Care Diagnostics Market, by Software, 2019-2028 (In $ Million)
Figure 6: Latin America Molecular Point of Care Diagnostics Market, by Infectious Disease, 2019-2028 (In $ Million)
Figure 7: Latin America Molecular Point of Care Diagnostics Market, by Respiratory, 2019-2028 (In $ Million)
Figure 8: Latin America Molecular Point of Care Diagnostics Market, by Hospital-Acquired Infections, 2019-2028 (In $ Million)
Figure 9: Latin America Molecular Point of Care Diagnostics Market, by Sexually-Transmitted Infections, 2019-2028 (In $ Million)
Figure 10: Latin America Molecular Point of Care Diagnostics Market, by Gastrointestinal Infections, 2019-2028 (In $ Million)
Figure 11: Latin America Molecular Point of Care Diagnostics Market, by Oncology, 2019-2028 (In $ Million)
Figure 12: Latin America Molecular Point of Care Diagnostics Market, by Prenatal, 2019-2028 (In $ Million)
Figure 13: Latin America Molecular Point of Care Diagnostics Market, by Others, 2019-2028 (In $ Million)
Figure 14: Latin America Molecular Point of Care Diagnostics Market, by Polymerase Chain Reaction, 2019-2028 (In $ Million)
Figure 15: Latin America Molecular Point of Care Diagnostics Market, by Real-Time Pcr (Q-Pcr), 2019-2028 (In $ Million)
Figure 16: Latin America Molecular Point of Care Diagnostics Market, by Digital Pcr (D-Pcr), 2019-2028 (In $ Million)
Figure 17: Latin America Molecular Point of Care Diagnostics Market, by Isothermal Nucleic Acid Amplification Technology, 2019-2028 (In $ Million)
Figure 18: Latin America Molecular Point of Care Diagnostics Market, by Other, 2019-2028 (In $ Million)
Figure 19: Latin America Molecular Point of Care Diagnostics Market, by Hospital, 2019-2028 (In $ Million)
Figure 20: Latin America Molecular Point of Care Diagnostics Market, by Clinics, 2019-2028 (In $ Million)
Figure 21: Latin America Molecular Point of Care Diagnostics Market, by Diagnostic Centers, 2019-2028 (In $ Million)
Figure 22: Latin America Molecular Point of Care Diagnostics Market, by Others, 2019-2028 (In $ Million)
Figure 23: Latin America Molecular Point of Care Diagnostics Market, Regional Outlook, 2018 & 2028 (In %)
Figure 24: Brazil Molecular Point of Care Diagnostics Market, 2019-2028 (In $ Million)
Figure 25: Mexico Molecular Point of Care Diagnostics Market, 2019-2028 (In $ Million)
Figure 26: Rest of Latin America Molecular Point of Care Diagnostics Market, 2019-2028 (In $ Million)